Pavel Mirovsky

2014

In 2014, Pavel Mirovsky earned a total compensation of $10.9M as President and General Manager, Europe at Valeant Pharmaceuticals International, a 1,226% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$330,000
Option Awards$3,816,896
Salary$499,274
Stock Awards$6,254,330
Other$23,272
Total$10,923,772

Mirovsky received $6.3M in stock awards, accounting for 57% of the total pay in 2014.

Mirovsky also received $330K in non-equity incentive plan, $3.8M in option awards, $499.3K in salary and $23.3K in other compensation.

Rankings

In 2014, Pavel Mirovsky's compensation ranked 444th out of 13,032 executives tracked by ExecPay. In other words, Mirovsky earned more than 96.6% of executives.

ClassificationRankingPercentile
All
444
out of 13,032
97th
Division
Manufacturing
153
out of 4,967
97th
Major group
Chemicals And Allied Products
48
out of 1,690
97th
Industry group
Drugs
38
out of 1,369
97th
Industry
Pharmaceutical Preparations
36
out of 1,042
97th
Source: SEC filing on April 9, 2015.

Mirovsky's colleagues

We found six more compensation records of executives who worked with Pavel Mirovsky at Valeant Pharmaceuticals International in 2014.

2014

Ari Kellen

Valeant Pharmaceuticals International

Group Chairman

2014

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2014

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2014

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2014

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2014

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

You may also like